JB CHEMICALS & PHARMACEUTICALS
|
JB CHEMICALS & PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
| Equity - Authorised | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr |
| Equity - Issued | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
| Equity Paid Up | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹1.00 | ₹1.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | ₹168 Cr | ₹140 Cr | ₹122 Cr | ₹63 Cr | - |
| Total Reserves | ₹3,250 Cr | ₹2,768 Cr | ₹2,343 Cr | ₹2,056 Cr | ₹1,794 Cr |
| Securities Premium | ₹164 Cr | ₹113 Cr | ₹70 Cr | ₹51 Cr | ₹51 Cr |
| Capital Reserves | ₹-0.04 Cr | ₹-0.04 Cr | ₹-0.04 Cr | ₹0.68 Cr | ₹0.68 Cr |
| Profit & Loss Account Balance | ₹2,935 Cr | ₹2,517 Cr | ₹2,125 Cr | ₹1,843 Cr | ₹1,585 Cr |
| General Reserves | ₹151 Cr | ₹151 Cr | ₹130 Cr | ₹130 Cr | ₹130 Cr |
| Other Reserves | ₹-0.04 Cr | ₹-13 Cr | ₹18 Cr | ₹31 Cr | ₹28 Cr |
| Reserve excluding Revaluation Reserve | ₹3,250 Cr | ₹2,768 Cr | ₹2,343 Cr | ₹2,056 Cr | ₹1,794 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹3,433 Cr | ₹2,923 Cr | ₹2,480 Cr | ₹2,134 Cr | ₹1,810 Cr |
| Minority Interest | - | - | - | ₹4.49 Cr | ₹3.71 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | ₹24 Cr | ₹383 Cr | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | ₹342 Cr | ₹520 Cr | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | ₹-318 Cr | ₹-137 Cr | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹169 Cr | ₹143 Cr | ₹96 Cr | ₹41 Cr | ₹50 Cr |
| Deferred Tax Assets | ₹31 Cr | ₹22 Cr | ₹18 Cr | ₹19 Cr | ₹22 Cr |
| Deferred Tax Liability | ₹200 Cr | ₹166 Cr | ₹114 Cr | ₹60 Cr | ₹72 Cr |
| Other Long Term Liabilities | ₹8.25 Cr | ₹11 Cr | ₹18 Cr | ₹24 Cr | ₹10 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹266 Cr | ₹288 Cr | ₹495 Cr | ₹410 Cr | ₹13 Cr |
| Total Non-Current Liabilities | ₹443 Cr | ₹466 Cr | ₹992 Cr | ₹475 Cr | ₹72 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹411 Cr | ₹356 Cr | ₹239 Cr | ₹224 Cr | ₹187 Cr |
| Sundry Creditors | ₹411 Cr | ₹356 Cr | ₹239 Cr | ₹224 Cr | ₹187 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹137 Cr | ₹436 Cr | ₹240 Cr | ₹81 Cr | ₹90 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹10 Cr | ₹13 Cr | ₹12 Cr | ₹4.32 Cr | ₹4.23 Cr |
| Interest Accrued But Not Due | - | - | ₹0.03 Cr | ₹0.01 Cr | ₹0.00 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹127 Cr | ₹423 Cr | ₹228 Cr | ₹77 Cr | ₹86 Cr |
| Short Term Borrowings | ₹14 Cr | ₹15 Cr | ₹28 Cr | ₹26 Cr | ₹33 Cr |
| Secured ST Loans repayable on Demands | ₹14 Cr | ₹15 Cr | ₹28 Cr | ₹26 Cr | ₹33 Cr |
| Working Capital Loans- Sec | ₹14 Cr | ₹15 Cr | ₹28 Cr | ₹26 Cr | ₹33 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-14 Cr | ₹-15 Cr | ₹-28 Cr | ₹-26 Cr | ₹-33 Cr |
| Short Term Provisions | ₹595 Cr | ₹480 Cr | ₹119 Cr | ₹123 Cr | ₹377 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹533 Cr | ₹431 Cr | ₹76 Cr | ₹78 Cr | ₹349 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹62 Cr | ₹49 Cr | ₹43 Cr | ₹46 Cr | ₹28 Cr |
| Total Current Liabilities | ₹1,157 Cr | ₹1,288 Cr | ₹626 Cr | ₹455 Cr | ₹687 Cr |
| Total Liabilities | ₹5,033 Cr | ₹4,677 Cr | ₹4,098 Cr | ₹3,069 Cr | ₹2,572 Cr |
| ASSETS | |||||
| Gross Block | ₹2,965 Cr | ₹2,835 Cr | ₹2,608 Cr | ₹1,876 Cr | ₹1,183 Cr |
| Less: Accumulated Depreciation | ₹996 Cr | ₹831 Cr | ₹707 Cr | ₹599 Cr | ₹549 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹1,968 Cr | ₹2,004 Cr | ₹1,901 Cr | ₹1,277 Cr | ₹634 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹47 Cr | ₹63 Cr | ₹44 Cr | ₹14 Cr | ₹26 Cr |
| Non Current Investments | ₹28 Cr | ₹24 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr |
| Long Term Investment | ₹28 Cr | ₹24 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹28 Cr | ₹24 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr |
| Long Term Loans & Advances | ₹276 Cr | ₹294 Cr | ₹514 Cr | ₹435 Cr | ₹5.62 Cr |
| Other Non Current Assets | ₹251 Cr | ₹6.03 Cr | ₹15 Cr | ₹1.04 Cr | ₹0.82 Cr |
| Total Non-Current Assets | ₹2,586 Cr | ₹2,404 Cr | ₹2,499 Cr | ₹1,745 Cr | ₹679 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹317 Cr | ₹365 Cr | ₹192 Cr | - | ₹665 Cr |
| Quoted | ₹317 Cr | ₹365 Cr | ₹192 Cr | - | ₹665 Cr |
| Unquoted | - | - | - | - | - |
| Inventories | ₹529 Cr | ₹503 Cr | ₹430 Cr | ₹410 Cr | ₹347 Cr |
| Raw Materials | ₹225 Cr | ₹196 Cr | ₹166 Cr | ₹152 Cr | ₹129 Cr |
| Work-in Progress | ₹21 Cr | ₹24 Cr | ₹36 Cr | ₹19 Cr | ₹24 Cr |
| Finished Goods | ₹103 Cr | ₹109 Cr | ₹123 Cr | ₹132 Cr | ₹138 Cr |
| Packing Materials | ₹37 Cr | ₹41 Cr | ₹46 Cr | ₹50 Cr | ₹29 Cr |
| Stores  and Spare | ₹1.00 Cr | ₹0.76 Cr | ₹0.79 Cr | ₹0.78 Cr | ₹0.41 Cr |
| Other Inventory | ₹141 Cr | ₹132 Cr | ₹58 Cr | ₹56 Cr | ₹27 Cr |
| Sundry Debtors | ₹815 Cr | ₹687 Cr | ₹576 Cr | ₹556 Cr | ₹389 Cr |
| Debtors more than Six months | ₹42 Cr | ₹22 Cr | ₹23 Cr | ₹36 Cr | ₹19 Cr |
| Debtors Others | ₹793 Cr | ₹680 Cr | ₹558 Cr | ₹524 Cr | ₹375 Cr |
| Cash and Bank | ₹129 Cr | ₹96 Cr | ₹79 Cr | ₹59 Cr | ₹31 Cr |
| Cash in hand | ₹0.04 Cr | ₹0.03 Cr | ₹0.04 Cr | ₹0.09 Cr | ₹0.13 Cr |
| Balances at Bank | ₹119 Cr | ₹96 Cr | ₹79 Cr | ₹44 Cr | ₹28 Cr |
| Other cash and bank balances | ₹10 Cr | - | - | ₹15 Cr | ₹2.43 Cr |
| Other Current Assets | ₹29 Cr | ₹33 Cr | ₹45 Cr | ₹57 Cr | ₹46 Cr |
| Interest accrued on Investments | ₹1.06 Cr | ₹0.51 Cr | ₹0.39 Cr | ₹0.04 Cr | ₹0.04 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹19 Cr | ₹16 Cr | ₹17 Cr | ₹12 Cr | ₹12 Cr |
| Other current_assets | ₹9.30 Cr | ₹16 Cr | ₹28 Cr | ₹45 Cr | ₹34 Cr |
| Short Term Loans and Advances | ₹627 Cr | ₹590 Cr | ₹277 Cr | ₹243 Cr | ₹416 Cr |
| Advances recoverable in cash or in kind | ₹19 Cr | ₹11 Cr | ₹14 Cr | ₹31 Cr | ₹3.71 Cr |
| Advance income tax and TDS | ₹525 Cr | ₹420 Cr | ₹71 Cr | ₹71 Cr | ₹358 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹84 Cr | ₹159 Cr | ₹192 Cr | ₹140 Cr | ₹54 Cr |
| Total Current Assets | ₹2,447 Cr | ₹2,273 Cr | ₹1,599 Cr | ₹1,325 Cr | ₹1,894 Cr |
| Net Current Assets (Including Current Investments) | ₹1,290 Cr | ₹985 Cr | ₹974 Cr | ₹869 Cr | ₹1,207 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹5,033 Cr | ₹4,677 Cr | ₹4,098 Cr | ₹3,069 Cr | ₹2,572 Cr |
| Contingent Liabilities | ₹132 Cr | ₹132 Cr | ₹105 Cr | ₹49 Cr | ₹54 Cr |
| Total Debt | ₹14 Cr | ₹357 Cr | ₹548 Cr | ₹26 Cr | ₹33 Cr |
| Book Value | 209.75 | 179.35 | 304.83 | 268.04 | 234.17 |
| Adjusted Book Value | 209.75 | 179.35 | 152.42 | 134.02 | 117.09 |
Compare Balance Sheet of peers of JB CHEMICALS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JB CHEMICALS & PHARMACEUTICALS | ₹27,728.4 Cr | 1.1% | 4.3% | 1.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
JB CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JB CHEMICALS & PHARMACEUTICALS | 1.1% |
4.3% |
1.2% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses